Description of a large island-wide outbreak of dengue in Puerto Rico, 2007.

Dengue is a mosquito-borne viral disease that affects 40% of the world's population. Nearly four million U.S. citizens live in dengue-endemic areas; the most affected population resides in Puerto Rico. Data from a dengue surveillance system were used to describe all suspected cases reported in Puerto Rico in 2007. Rates of infection per 10,000 residents were calculated by age, sex, and residence. Rates and clinical outcomes were compared with those from outbreaks in 1994-1995 and 1998. In 2007, 10,508 suspected cases were reported; 52.5% persons were hospitalized, 31.8% reported hemorrhage, 2.2% had dengue hemorrhage fever, and 44 died. A total of 3,293 (33.0%) of processed specimens were laboratory positive for dengue virus (DENV); DENV-3 (1,342, 61.7%) and DENV-2 (677, 31.1%) were detected most often. The overall incidence of laboratory-positive dengue was 8.6 infections per 10,000 population. Rates were highest among persons 10-14 years of age (19.0), followed by persons 15-19 years of age (17.9) and infants (10.9). Higher rates of hospitalization and hemorrhage were reported in 2007 than in 1994-1995 or 1998. United States citizens residing in Puerto Rico are at risk of acquiring dengue. Data suggest that the severity is worsening, and persons 10-19 years of age and infants continue to be most affected.

[1]  Y. Eshita,et al.  Molecular epidemiology of dengue virus serotypes 2 and 3 in Paraguay during 2001-2006: the association of viral clade introductions with shifting serotype dominance. , 2008, Virus research.

[2]  E. Fish.  The X-files in immunity: sex-based differences predispose immune responses , 2008, Nature Reviews Immunology.

[3]  J. Farrar,et al.  High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection , 2007, PloS one.

[4]  I. Chaudry,et al.  Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches. , 2006, Clinics.

[5]  D. Gubler,et al.  Dengue Prevention and 35 Years of Vector Control in Singapore , 2006, Emerging infectious diseases.

[6]  G. Chang,et al.  Development of Real-Time Reverse Transcriptase PCR Assays To Detect and Serotype Dengue Viruses , 2006, Journal of Clinical Microbiology.

[7]  E. Harris,et al.  Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. , 2005, The American journal of tropical medicine and hygiene.

[8]  D. Lubahn,et al.  Estrogen Receptor α (ERα) Deficiency in Macrophages Results in Increased Stimulation of CD4+ T Cells while 17β-Estradiol Acts through ERα to Increase IL-4 and GATA-3 Expression in CD4+ T Cells Independent of Antigen Presentation1 , 2005, The Journal of Immunology.

[9]  M. Heineman,et al.  Sex hormones and the immune response in humans. , 2005, Human reproduction update.

[10]  D. Guha-Sapir,et al.  Dengue fever: new paradigms for a changing epidemiology , 2005, Emerging themes in epidemiology.

[11]  Christine M Pfeiffer,et al.  Hematological and iron-related analytes--reference data for persons aged 1 year and over: United States, 1988-94. , 2005, Vital and health statistics. Series 11, Data from the National Health Survey.

[12]  T. Lang.  Estrogen as an immunomodulator. , 2004, Clinical immunology.

[13]  Sasithon Pukrittayakamee,et al.  Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand , 2004, Tropical medicine & international health : TM & IH.

[14]  D. Lubahn,et al.  Estrogen receptor‐α deficiency promotes increased TNF‐α secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro , 2004 .

[15]  E. Holmes,et al.  Selection-driven evolution of emergent dengue virus. , 2003, Molecular biology and evolution.

[16]  D. Gubler,et al.  Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus , 2003, Emerging infectious diseases.

[17]  Donald S Burke,et al.  Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. , 2003, The American journal of tropical medicine and hygiene.

[18]  G. Clark,et al.  The reappearance of dengue-3 and a subsequent dengue-4 and dengue-1 epidemic in Puerto Rico in 1998. , 2002, The American journal of tropical medicine and hygiene.

[19]  D. Gubler.  Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. , 2002, Trends in microbiology.

[20]  Y. S. Lin,et al.  Immunopathogenesis of dengue virus infection. , 2001, Journal of biomedical science.

[21]  E. Ooi,et al.  Dengue seroepidemiology in Singapore , 2001, The Lancet.

[22]  S. Klein,et al.  The effects of hormones on sex differences in infection: from genes to behavior , 2000, Neuroscience & Biobehavioral Reviews.

[23]  Denise A. Martin,et al.  Detection of Anti-Arboviral Immunoglobulin G by Using a Monoclonal Antibody-Based Capture Enzyme-Linked Immunosorbent Assay , 2000, Journal of Clinical Microbiology.

[24]  H. Schatzmayr,et al.  Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[25]  J. Rigau-Pérez.  Surveillance for an emerging disease: dengue hemorrhagic fever in Puerto Rico, 1988-1997. Puerto Rico Association of Epidemiologists. , 1999, Puerto Rico health sciences journal.

[26]  J. Rigau-Pérez,et al.  Hospitalizations for suspected dengue in Puerto Rico, 1991-1995: estimation by capture-recapture methods. The Puerto Rico Association of Epidemiologists. , 1999, The American journal of tropical medicine and hygiene.

[27]  P. Zabel,et al.  Gender differences in human sepsis. , 1998, Archives of surgery.

[28]  D. Gubler,et al.  Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994. , 1998, The American journal of tropical medicine and hygiene.

[29]  Dietz,et al.  The 1986 dengue and dengue hemorrhagic fever epidemic in Puerto Rico: epidemiologic and clinical observations. , 1996, Puerto Rico health sciences journal.

[30]  G. Lockitch,et al.  Age- and sex-specific pediatric reference intervals: study design and methods illustrated by measurement of serum proteins with the Behring LN Nephelometer. , 1988, Clinical chemistry.

[31]  S. Nimmannitya.  Dengue haemorrhagic fever in Thailand. , 1987, The Southeast Asian journal of tropical medicine and public health.

[32]  R. Novak,et al.  Dengue transmission in two Puerto Rican communities in 1982. , 1985, The American journal of tropical medicine and hygiene.

[33]  D. Burke,et al.  Antibody Capture Immunoassay Detection of Japanese Encephalitis Virus Immunoglobulin M and G Antibodies in Cerebrospinal Fluid , 1982, Journal of clinical microbiology.

[34]  D. Gubler,et al.  The use of mosquitoes to detect and propagate dengue viruses. , 1974, The American journal of tropical medicine and hygiene.

[35]  B. Henderson,et al.  An epidermiologic study of dengue type 2 in Puerto Rico, 1969. , 1973, American journal of epidemiology.

[36]  S. Halstead.  Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. , 1970, The Yale journal of biology and medicine.

[37]  L. Morris,et al.  Dengue fever in a Puerto Rican community. , 1967, American journal of epidemiology.

[38]  J. Ordonez,et al.  Recovery of dengue viruses from patients during epidemics in Puerto Rico and East Pakistan. , 1966, The American journal of tropical medicine and hygiene.

[39]  Dengue haemorrhagic fever Diagnosis , treatment , prevention and control , 2010 .

[40]  I. Marriott,et al.  Sexual dimorphism in innate immune responses to infectious organisms , 2006, Immunologic research.

[41]  D. Lubahn,et al.  Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation. , 2005, Journal of immunology.

[42]  P. Díaz-Dueñas,et al.  Clinical Pattern of Hospitalized Patients during a Dengue Epidemic in Colima, Mexico , 2005 .

[43]  D. Lubahn,et al.  Estrogen receptor-alpha deficiency promotes increased TNF-alpha secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro. , 2004, Journal of leukocyte biology.

[44]  D. Vaughn,et al.  Dengue epidemiology: virus epidemiology, ecology, and emergence. , 2003, Advances in virus research.

[45]  R. Lanciotti.  Molecular amplification assays for the detection of flaviviruses. , 2003, Advances in virus research.

[46]  G. Clark,et al.  The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. , 2001, The American journal of tropical medicine and hygiene.

[47]  G. Crane.  Dengue haemorrhagic fever: diagnosis, treatment, prevention and control , 1999 .

[48]  D. Stanley.  Tietz Textbook of Clinical Chemistry , 1999 .

[49]  V. Gunn,et al.  The Harriet Lane handbook : a manual for pediatric house officers , 1996 .

[50]  L. Rosen,et al.  Dengue hemorrhagic fever. , 1996, Bulletin de la Societe de pathologie exotique.

[51]  C. Brugnara,et al.  Pediatric Reference Ranges , 1995 .

[52]  C. G. Moore,et al.  Dengue in Puerto Rico, 1977: public health response to characterize and control an epidemic of multiple serotypes. , 1986, The American journal of tropical medicine and hygiene.

[53]  G. Kuno,et al.  Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. , 1984, The American journal of tropical medicine and hygiene.

[54]  Waldo Emerson Nelson,et al.  Textbook of Pediatrics , 1969 .